IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF P210 BCR/ABL SUBSTRATE
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF P210 BCR/ABL SUBSTRATE
批准号:
6102990
负责人:
BAYARD D CLARKSON
金额:
$24.43万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-06-01 至 2000-05-31
关键词:
biological signal transduction cell growth regulation cell line cell transformation cellular oncology chronic myelogenous leukemia cyclins enzyme activity enzyme substrate growth factor immunoprecipitation molecular cloning molecular oncology nucleic acid sequence oncoproteins phosphorylation protein purification protein sequence protein structure function protein tyrosine kinase protooncogene western blottings
中文摘要
这个项目广泛的长期目标是理解,在一个分子上
水平,p210BCR/ABL蛋白酪氨酸激酶活性最终如何
导致慢性期CML的髓样扩张。为了实现这一目标
为了实现这一目标,必须:(A)确定和描述
相关的p210bcr/abl底物及其相互作用,在初级
免疫沉淀诱导原始慢性期CML细胞分化
用已知蛋白质或蛋白质的有效抗体进行免疫印迹
一代抗体的纯化、测序和克隆,
潜在的新蛋白质;(B)确定该蛋白的生物学功能
相关底物。确定构成酪氨酸是否
慢性粒细胞白血病原发原始慢性期一种底物的磷酸化
通过检查原始的原始的和成熟的是异常的或不合时宜的
正常亚群;(D)确定生长因子信号
相关底物可能参与的转导途径。
该项目的具体目标是:目标1.进一步确定和
鉴定相关的p210 BCR/ABL底物和信号转导
原发原始慢性期CML细胞影响的通路:(1A)
其他已知相关底物的特性;(1c)进一步
相关底物的鉴定;(Id)P-Tyr的鉴定
原代原始正常母细胞中KIT配体途径中的蛋白质。目标2.
P56基因的分离、测序和鉴定;(2a)cdna克隆和
测序;(2b)抗体生产;(2c)功能分析。目标3.
分析其酪氨酸蛋白p155的结构和功能
原代CML原始细胞(3a)的磷酸化水平进一步升高
原发慢性期CML细胞中p155和p210的表达特征
表达bcr/abl的细胞系;(3b)p155的纯化;(3c)克隆和
对p155(Ed)功能分析进行排序。
英文摘要
The broad long term goal of this project is to understand, on a molecular
level, how the p210 bcr/abl protein tyrosine kinase activity ultimately
causes a myeloid expansion in chronic phase CML. In order to achieve this
objective, it becomes essential to: (a) Identify and characterize the
relevant p210bcr/abl substrates, and their interactions, in primary
primitive chronic phase CML blasts by immunoprecipitation and
immunoblotting with available antibodies to known proteins or by protein
purification, sequencing and cloning of, an generation of antibodies to,
potential novel proteins; (b) Ascertain the biological functions of the
relevant substrates. Ascertain whether the constitutive tyrosine
phosphorylation of a substrate in primary primitive chronic phase CML
blasts is aberrant or untimely by examining primary primitive and maturing
normal subpopulations; (d) Determine the growth factor signal
transduction pathways in which the relevant substrates may be involved.
The specific aims of the project are: Aim 1. To further identify and
characterize the relevant p210 bcr/abl substrates and signal transduction
pathways affected in primary primitive chronic phase CML blasts: (1a)
Characterization of other known relevant substrates; (1c) Further
identification of relevant substrates; (id) Identification of P-tyr
proteins in kit ligand pathway in primary primitive normal blasts. Aim 2.
To isolate, sequence and characterize p56; (2a) cDNA cloning and
sequencing; (2b) Antibody production; (2c) Functional analyses. Aim 3.
To analyze the structure and function of p155, a protein whose tyrosine
phosphorylation is elevated in primary CML blasts (3a) Further
characterization of p155 in primary chronic phase CML blasts and p210
bcr/abl expressing cell lines; (3b) Purification of p155; (3c) Cloning and
sequencing p p155 (ed) Functional analyses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF P210 BCR/ABL SUBSTRATE
-
批准号:6316960
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2000
-
负责人:BAYARD D CLARKSON
-
依托单位:
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF P210 BCR/ABL SUBSTRATE
-
批准号:6499788
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2000
-
负责人:BAYARD D CLARKSON
-
依托单位:
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF P210 BCR/ABL SUBSTRATE
-
批准号:6269665
-
项目类别:
-
资助金额:$23.53万
-
财政年份:1998
-
负责人:BAYARD D CLARKSON
-
依托单位:
IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF P210 BCR/ABL SUBSTRATE
-
批准号:6237481
-
项目类别:
-
资助金额:$21.91万
-
财政年份:1997
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:2406307
-
项目类别:
-
资助金额:$87.62万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SELECTIVE THERAPY OF CHRONIC MYELOID LEUKEMIA
-
批准号:2107172
-
项目类别:
-
资助金额:$50.0万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SELECTIVE THERAPY OF CHRONIC MYELOID LEUKEMIA
-
批准号:2107173
-
项目类别:
-
资助金额:$53.48万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:6571432
-
项目类别:
-
资助金额:$120.35万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SELECTIVE THERAPY OF CHRONIC MYELOID LEUKEMIA
-
批准号:2107174
-
项目类别:
-
资助金额:$54.81万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:6495836
-
项目类别:
-
资助金额:$13.82万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:6172387
-
项目类别:
-
资助金额:$100.6万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:6774089
-
项目类别:
-
资助金额:$122.13万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:6944527
-
项目类别:
-
资助金额:$125.59万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:2712706
-
项目类别:
-
资助金额:$94.13万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:2895163
-
项目类别:
-
资助金额:$97.74万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:7274124
-
项目类别:
-
资助金额:$133.55万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
SEARCH FOR SELECTIVE THERAPY OF CML
-
批准号:7127288
-
项目类别:
-
资助金额:$134.45万
-
财政年份:1994
-
负责人:BAYARD D CLARKSON
-
依托单位:
YOUNG MINORITY SCIENTISTS IN THE FIELD OF CANCER
-
批准号:2414138
-
项目类别:
-
资助金额:$7.32万
-
财政年份:1985
-
负责人:BAYARD D CLARKSON
-
依托单位:
Young Minority Scientists in the Field of Cancer
-
批准号:8323978
-
项目类别:
-
资助金额:$9.9万
-
财政年份:1985
-
负责人:BAYARD D CLARKSON
-
依托单位:
Young Minority Scientists in the Field of Cancer
-
批准号:7232748
-
项目类别:
-
资助金额:$8.95万
-
财政年份:1985
-
负责人:BAYARD D CLARKSON
-
依托单位:
海外基金